A Statistical Model of the International Spread of Wild Poliovirus in Africa Used to Predict and Prevent Outbreaks
Background:
Outbreaks of poliomyelitis in African countries that were previously free of wild-type poliovirus cost the Global Polio Eradication Initiative US$850 million during 2003–2009, and have limited the ability of the program to focus on endemic countries. A quantitative understanding of the factors that predict the distribution and timing of outbreaks will enable their prevention and facilitate the completion of global eradication.
Methods and Findings:
Children with poliomyelitis in Africa from 1 January 2003 to 31 December 2010 were identified through routine surveillance of cases of acute flaccid paralysis, and separate outbreaks associated with importation of wild-type poliovirus were defined using the genetic relatedness of these viruses in the VP1/2A region. Potential explanatory variables were examined for their association with the number, size, and duration of poliomyelitis outbreaks in 6-mo periods using multivariable regression analysis. The predictive ability of 6-mo-ahead forecasts of poliomyelitis outbreaks in each country based on the regression model was assessed. A total of 142 genetically distinct outbreaks of poliomyelitis were recorded in 25 African countries, resulting in 1–228 cases (median of two cases). The estimated number of people arriving from infected countries and <5-y childhood mortality were independently associated with the number of outbreaks. Immunisation coverage based on the reported vaccination history of children with non-polio acute flaccid paralysis was associated with the duration and size of each outbreak, as well as the number of outbreaks. Six-month-ahead forecasts of the number of outbreaks in a country or region changed over time and had a predictive ability of 82%.
Conclusions:
Outbreaks of poliomyelitis resulted primarily from continued transmission in Nigeria and the poor immunisation status of populations in neighbouring countries. From 1 January 2010 to 30 June 2011, reduced transmission in Nigeria and increased incidence in reinfected countries in west and central Africa have changed the geographical risk of polio outbreaks, and will require careful immunisation planning to limit onward spread.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
A Statistical Model of the International Spread of Wild Poliovirus in Africa Used to Predict and Prevent Outbreaks. PLoS Med 8(10): e32767. doi:10.1371/journal.pmed.1001109
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001109
Souhrn
Background:
Outbreaks of poliomyelitis in African countries that were previously free of wild-type poliovirus cost the Global Polio Eradication Initiative US$850 million during 2003–2009, and have limited the ability of the program to focus on endemic countries. A quantitative understanding of the factors that predict the distribution and timing of outbreaks will enable their prevention and facilitate the completion of global eradication.
Methods and Findings:
Children with poliomyelitis in Africa from 1 January 2003 to 31 December 2010 were identified through routine surveillance of cases of acute flaccid paralysis, and separate outbreaks associated with importation of wild-type poliovirus were defined using the genetic relatedness of these viruses in the VP1/2A region. Potential explanatory variables were examined for their association with the number, size, and duration of poliomyelitis outbreaks in 6-mo periods using multivariable regression analysis. The predictive ability of 6-mo-ahead forecasts of poliomyelitis outbreaks in each country based on the regression model was assessed. A total of 142 genetically distinct outbreaks of poliomyelitis were recorded in 25 African countries, resulting in 1–228 cases (median of two cases). The estimated number of people arriving from infected countries and <5-y childhood mortality were independently associated with the number of outbreaks. Immunisation coverage based on the reported vaccination history of children with non-polio acute flaccid paralysis was associated with the duration and size of each outbreak, as well as the number of outbreaks. Six-month-ahead forecasts of the number of outbreaks in a country or region changed over time and had a predictive ability of 82%.
Conclusions:
Outbreaks of poliomyelitis resulted primarily from continued transmission in Nigeria and the poor immunisation status of populations in neighbouring countries. From 1 January 2010 to 30 June 2011, reduced transmission in Nigeria and increased incidence in reinfected countries in west and central Africa have changed the geographical risk of polio outbreaks, and will require careful immunisation planning to limit onward spread.
: Please see later in the article for the Editors' Summary
Zdroje
1. World Health Organization 2010 Progress towards interruption of wild poliovirus transmission worldwide, 2009. Wkly Epidemiol Rec 85 178 184
2. World Health Organization 1993 Progress toward global eradication of poliomyelitis, 1988–1991. MMWR Morb Mortal Wkly Rep 42 486 487, 493–495
3. World Health Organization 2009 Progress toward poliomyelitis eradication—Nigeria, January 2008–July 2009. MMWR Morb Mortal Wkly Rep 58 1150 1154
4. World Health Organization 2011 Progress toward interrupting wild poliovirus circulation in countries with reestablished transmission—Africa, 2009–2010. MMWR Morb Mortal Wkly Rep 60 306 311
5. World Health Organization 2011 Poliomyelitis outbreak—Republic of the Congo, September 2010–February 2011. MMWR Morb Mortal Wkly Rep 60 312 313
6. Global Polio Eradication Initiative 2010 Global Polio Eradication Initiative strategic plan 2010–2012 Geneva World Health Organization
7. Wilder-SmithATambyahPA 2007 The spread of poliomyelitis via international travel. Trop Med Int Health 12 1137 1138
8. GershonAAHotezPJKatzS 2003 Krugman's infectious diseases of children St. Louis (Missouri) Mosby 822
9. KewOMMuldersMNLipskayaGYdaSilvaEEPallanschMA 1995 Molecular epidemiology of polioviruses. Semin Virol 6 401 414
10. LiuHMZhengDPZhangLBObersteMSPallanschMA 2000 Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol 74 11153 11161
11. ShulmanLMHandsherRYangCFYangSJManorJ 2000 Resolution of the pathways of poliovirus type 1 transmission during an outbreak. J Clin Microbiol 38 945 952
12. GrasslyNCJafariHBahlSDurraniSWengerJ 2010 Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination. J Infect Dis 201 1535 1543
13. JenkinsHEAylwardRBGasasiraADonnellyCAAbanidaEA 2008 Effectiveness of immunization against paralytic poliomyelitis in Nigeria. N Engl J Med 359 1666 1674
14. GrasslyNCWengerJDurraniSBahlSDeshpandeJM 2007 Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study. Lancet 369 1356 1362
15. OAG 2004 Products and services: outgoing flight data from Nigeria from January–December 2004 [database] Bedfordshire (UK) OAG
16. Development Research Centre on Migration, Globalisation, and Poverty 2007 March Global migrant origin database [database]. Available: http://www.migrationdrc.org/research/typesofmigration/global_migrant_origin_database.html. Accessed 25 June 2010
17. World Tourism Organization 2010 Tourism factbook [database]. Available: http://www.wtoelibrary.org/content/v486k6/?v=search. Accessed 2 May 2010
18. XiaYBjornstadONGrenfellBT 2004 Measles metapopulation dynamics: a gravity model for epidemiological coupling and dynamics. Am Nat 164 267 281
19. Rabe-HeskethSSkrondalA 2005 Multilevel and longitudinal modelling using STATA College Station (Texas) Stata Press
20. KleinbaumDG 1998 Applied regression analysis and other multivariable methods London Duxbury Press
21. DybaTHakulinenTPaivarintaL 1997 A simple non-linear model in incidence prediction. Stat Med 16 2297 2309
22. FieldingAHBellJF 1997 A review of methods for the assessment of prediction errors in conservation presence/absence models. Environ Conserv 24 38 49
23. BrookerSHaySIBundyDA 2002 Tools from ecology: useful for evaluating infection risk models? Trends Parasitol 18 70 74
24. PepeMSLongtonGJanesH 2009 Estimation and comparison of receiver operating characteristic curves. Stata J 9 1 16
25. CoxDROakesD 1984 Analysis of survival data. Monographs on statistics and applied probability 21 London Chapman and Hall
26. HilbeJM 2007 Negative binomial regression Cambridge Cambridge University Press
27. Global Polio Eradication Initiative 2011 Monthly situation report—July 2011 Geneva Global Polio Eradication Initiative Available: http://www.polioeradication.org/Mediaroom/Monthlysituationreports/2011/July.aspx. Accessed 16 September 2011
28. World Health Organization 2010 WHO/UNICEF estimates of national immunization coverage. Available: http://www.who.int/immunization_monitoring/routine/immunization_coverage/en/index4.html. Accessed 15 April 2010
29. World Health Organization 2009 Polio campaign monitoring. Available: http://www.polioeradication.org/Dataandmonitoring/Poliocampaignmonitoring.aspx. Accessed 16 September 2011
30. GrasslyNCFraserCWengerJDeshpandeJMSutterRW 2006 New strategies for the elimination of polio from India. Science 314 1150 1153
31. LawnJEKinneyMVKerberKJBlackRECohenB 2010 Sub-Saharan Africa's mothers, newborns, and children: where and why do they die? PLoS Med 7 e1000294 doi:10.1371/journal.pmed.1000294
32. BryceJGilroyKJonesGHazelEBlackRE 2010 The Accelerated Child Survival and Development programme in west Africa: a retrospective evaluation. Lancet 375 572 582
33. US Central Intelligence Agency 2011 The world factbook [database] Washington (District of Columbia) US Central Intelligence Agency Available: https://www.cia.gov/library/publications/the-world-factbook/. Accessed 16 September 2011
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 10
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
Najčítanejšie v tomto čísle
- STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): An Extension of the STROBE Statement
- The Effect of Chromosome 9p21 Variants on Cardiovascular Disease May Be Modified by Dietary Intake: Evidence from a Case/Control and a Prospective Study
- Universal Definition of Loss to Follow-Up in HIV Treatment Programs: A Statistical Analysis of 111 Facilities in Africa, Asia, and Latin America
- Estimating Infection Attack Rates and Severity in Real Time during an Influenza Pandemic: Analysis of Serial Cross-Sectional Serologic Surveillance Data